Sean A. McCarthy - Mar 16, 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Stock symbol
CTMX
Transactions as of
Mar 16, 2023
Transactions value $
-$13,391
Form type
4
Date filed
3/20/2023, 06:43 PM
Previous filing
Feb 6, 2023
Next filing
May 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$13.4K -7.12K -1.8% $1.88 389K Mar 16, 2023 Direct F1, F2
holding CTMX Common Stock 93.2K Mar 16, 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 161,250 restricted stock units.
F3 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.